Epigallocatechin gallate induced apoptosis in Sarcoma180 cells in vivo: Mediated by p53 pathway and inhibition in U1B, U4-U6 UsnRNAs expression

Apoptosis

Volumn 11, Issue 12, 2006, Pages 2267-2276

  Manna, Sugata ^a   Banerjee, Sarmistha ^a   Mukherjee, Sudeshna ^a   Das, Sukta ^a   Panda, Chinmay Kr ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Apoptosis; Chemoprevention; Epigallocatechin gallate; In vivo S180; Uridylic acid rich small nuclear RNAs

Indexed keywords

CYCLIN D1; DNA FRAGMENT; EPIGALLOCATECHIN GALLATE; MYC PROTEIN; POLYPHENOL DERIVATIVE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MDM2; PROTEIN P21; PROTEIN P27; PROTEIN P53; RNA U5; RNA U6; SMALL NUCLEAR RNA; U1B RIBONUCLEIC ACID; URIDINE PHOSPHATE; URIDYLIC ACID RICH SMALL NUCLEAR RIBONUCLEIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL GROWTH; CELL STRAIN; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSE COMPARISON; FLOW CYTOMETRY; GENE EXPRESSION; IN VIVO STUDY; INHIBITION KINETICS; INOCULATION; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA CELL; SPLICEOSOME; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CATECHIN; CELL CYCLE; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; IN SITU NICK-END LABELING; INJECTIONS, INTRAPERITONEAL; MICE; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL NUCLEAR; SARCOMA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33845357645     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-0198-2     Document Type: Article

References (63)

1. Yang CS, Maliakal P, Meng X (2002) Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42:25-54
2. Weisburger JH (1999) Tea and health: the underlying mechanisms. Proc Soc Exp Biol Med 220:271-275
3. Adhami VM, Afaq Farrukh, Ahamad N, Hara Y, Mukhtar H (2004) Tea polyphenols as cancer chemopreventive agents. In: Kelloff GJ, Hawk ET, Sigman CC (eds), Cancer chemoprevention, promising cancer chemoprevention agents. Humana Press Inc., Totowa, NJ, vol 1, pp 437-449
4. Lin JK, Liang YC (2000) Cancer chemoprevention by tea polyphenols. Proc Natl Sci Counc 24(1):1-13
5. Qanungo S, Das M, Haldar S, Basu A (2005) Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis 26(5):958-967
6. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H (1997) Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma. J Natl Cancer Inst 89(24):1881-1886
7. Chen C, Shen G, Hebbar V, Hu R, Owuor ED, Kong A-NT (2003) Epigallocatechin -3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis 24(8):1369-1378
8. Jia X, Han C, Chen J (2002) Effects of tea on preneoplastic lesions and cell cycle regulators in rat liver. Cancer Epidemiol Biomarkers Prevention 11:1663-1667
9. Gupta S, Hastak K, Ahamad N, Lewin JS, Mukhtar H (2001) The inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Nat Acad Sci 98(18):10350-10355
10. Bhattacharyya A, Choudhury T, Pal S et al (2003) Apoptogenic effects of black tea on Ehrlich's ascites carcinoma cell. Carcinogenesis 24(1):75-80
11. Bode AM, Dong Z (2003) Signal transduction pathways: targets for green and black tea polyphenols. J Biochem Mol Biol 36(1):66-77
12. Surh YJ (2003) Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer 3:768-780
13. Kuo PL, Lin CC (2003) Green tea constituent (-)-epigallocatechin-3- gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53 dependent and Fas-mediated pathways. J Biomed Sci 10:291-297
14. Ju J, Hong J, Zhou JN et al (2005) Inhibition of intestinal tumorigenesis in Apcmin/+mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res 65(22):10623-10631
15. Ran ZH, Jou J, Xiao SD (2005) Experimental study on antineoplastic activity of epigallocatechin-3-gallate to digestive tract carcinomas. Chin Med J Engl 118(16):1330-1337
16. Levites Y, Amit T, Youdim MB, Mandel S (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 277(34):30574-30580
17. Huh SW, Bae SM, Kim YW et al (2004) Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines. Gyneocol Oncol 94(3):760-768
18. Gupta S, Hussain T, Mukhtar H (2003) Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 410(1):177-185
19. Bartek J, Lukas J (2001) Mammalian G1- and S-phase checkpoints in response to DNA damage. Current opinion Cell Biol 13:738-747
20. Yee KS, Vousden KH (2005) Complicating the complexity of p53. Carcinogenesis 26(8):1317-1322
21. Lowe SW, Lin AW (2000) Apoptosis in cancer. Carcinogenesis 21(3):485-495
22. Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20:1803-1815
23. Gridasova AA, Henry RW (2005) The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerase II and III independently of sequence-specific DNA binding. Mol cell Biol 25(8):3247-3260
24. Crains CA, White RJ (1998) p53 is a general repressor of RNA polymerase III transcription. EMBO J 17:3112-3123
25. Chesnokov I, Chu WM, Botchan MR, Schmid CW (1996) p53 inhibits RNA polymerase III-directed transcription in a promoter-dependent manner. Mol Cell Biol 16:7084-7088
26. Manna S, Banerjee S, Saha P, Roy A, Das S, Panda CK (2006) Differential alterations in metabolic pattern of the spliceosomal UsnRNAs during pre-malignant lung lesions induced by benzo(a)pyrene: modulation by tea polyphenols. Mol Cell Biochem (in press)
27. Ray R, Ray K, Panda CK (1997) Differential alterations in metabolic pattern of the six major UsnRNAs during development. Mol Cell Biochem 177:79-88
28. Lund E, Kahan B, Dahlberg JE (1985) Differential control of U1 small nuclear RNA expression during mouse development. Science 229(4719):1271-1274
29. Lund E, Dahlberg JE (1987) Differential accumulation of U1 and U4 small nuclear RNAs during Xenopus development. Genes Dev 1(1):39-46
30. Hanley BA, Schuler MA (1991) Developmental expression of plant snRNAs. Nucl Acids Res 19(22):6319-6325
31. Forbes DJ, Kirschner MW, Caput D, Dahlberg JE, Laund E (1984) Differential expression of multiple U1 small nuclear RNAs in oocytes and embryos of Xenopus laevis. Cell 38(3):681-689
32. Dahlberg JE, Lund E (1987) Structure and expression of U-snRNA genes. Mol Biol Rep 12(3):139-143
33. Reddy R, Henning D, Busch H (1979) Nucleotide sequence of nuclear U3B RNA. J Biol Chem 254(21):11097-11105
34. Degen WGJ, Aarssen YV, Pruijn GJM, Utz PJ, Venrooij WJV (2000) The fate of U1 snRNP during anti-Fas induced apoptosis: Specific cleavage of the U1 snRNA molecule. Cell Death Differentiation 7:70-79
35. Siddiqi M, Das S (1999) Tea as anticarcinogenic agent. In: Jain NK (ed), Global Advances in Tea Science. Aravali Books International, New Delhi, pp 359-368
36. Banerjee S, Manna S, Saha P, Panda CK, Das S (2005) Black tea polyphenols suppress cell proliferation and induce apoptosis during benzo(a)pyrene-induced lung carcinogenesis. Eur J Cancer Prev 14(3):215-221
37. Ganguly C, Saha P, Panda CK, Das S (2005) Inhibition of growth, induction of apoptosis and alteration of gene expression by tea polyphenols in the highly metastatic human lung cancer cell line NCI-H460. Asian Pac J Cancer Prev 6(3):326-331
38. Saha P, Banerjee S, Ganguly C, Manna S, Panda CK, Das S (2005) Black tea extract can modulate protein expression of H-ras, c-Myc, p53, and Bcl-2 genes during pulmonary hyperplasia, dysplasia, and carcinoma in situ. J Envir Pathol Toxicol Oncol 24(3):211-224
39. Holmes KL, Otten G, Yokoyama WM (2001) Flow cytometry analysis using the Becton Dickinson FACS Calibur. In: Coligan JE, Bierrer BE, Margulies DH, Shevach EM, Strober W (eds) Current protocols in immunology. John Wiley & Sons Inc., USA, vol 1, pp 5.4.1-5.4.22
40. Yoshida A, Shao R, Pommier Y (1999) Assessment of DNA damage in apoptosis. In: Studzinski GP (ed) Apoptosis: a practical approach. Oxford University Press, New York, pp 41-55
41. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York
42. Hernandez I, Maddison LA, Wei Y, et al. (2003) Prostate-specific expression of p53R172L differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival. Mol Cancer Res 1:1036-1047
43. Tsuruyama T, Nakamura T, Jin G, Ozeki M, Yamada Y, Hiai H (2002) Constitutive activation of Stat5a by retrovirus integration in early pre-B lymphomas of SL/Kh strain mice. Proc Nat Acad Sci 99(12):8253-8258
44. Pereira MA, Kramer PM, Conran PB, Tao L (2001) Effect of chloroform on dichloroacetic acid and trichloroacetic acid-induced hypomethylation and expression of the c-myc gene and on their promotion of liver and kidney tumors in mice. Carcinogenesis 22(9):1511-1519
45. Wu C, Fujihara H, Yao J et al (2003) Different expression patterns of Bcl-2, Bcl-xl and Bax proteins after sublethal forebrain ischemia in C57black/Crj6 mouse Striatum. Stroke 34:1803-1808
46. Wang X, Michael D, Murcia GD, Oren M (2002) P53 activation by nitric oxide involves down-regulation of mdm2. J Biol Chem 277(18):15697-15702
47. Castro IPD, Malumbres M, Santos J, Pellicer A, Piqueras JF (1999) Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas. Carcinogenesis 20(9):1675-1682
48. Pereira MA, Li Y, Gunning WT et al (2002) Prevention of mouse lung tumors by budesonide and its modulation of biomarkers. Carcinogenesis 23(7):1185-1192
49. Herold C, Ocker M, Ganslmayer M, Gerauer H, Hahn EG, Schuppan D (2002) Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. British J Cancer 86:443-448
50. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature Lond 227:680-685
51. Choudhury K, Choudhury I, Jones RW, Thirunavukkarasu C, Eliceiri GL (1988) Metabolism of U6 RNA species in non-irradiated and UV-irradiated mammalian cells. J Cell Physiol 137(3):529-536
52. Sherr CJ (1996) Cancer cell cycles. Science 274:1672-1677
53. Pelengaris S, Khan M, Evan G (2002) C-Myc: more than just a matter of life and death. Nature Reviews Cancer 2:764-776
54. Vargas DA, Ronai Z (2002) P53-Mdm2-the affair that never ends. Carcinogenesis 23(4):541-547
55. Fujiki H, Suganuma M, Okabe S et al (1998) Cancer inhibition by green tea. Mutant Res 402(1-2):307-310
56. Okabe S, Suganuma M, Hayashi M, Sueoka E, Komori A, Fujiki H (1997) Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn J Cancer Res 88(7):639-643
57. Ahmad N, Cheng P, Mukhtar H (2000) Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun 275(2):328-334
58. Boxer LM, Dang CV (2001) Translocations involving c-myc and c-myc function. Oncogene 20:5595-5610
59. Masuda M, Suzui M, Weinstein IB (2001) Effects of epigallocatechin-3- gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clinical Cancer Res 7:4220-4229
60. Hamad K, Kumazaki T, Mizuno K, Yokoro K (1989) A small nuclear RNA U5, can transform cells in vitro. Mol Cell Biol 9(10):4345-4356
61. Eliceiri BP, Choudhury K, Scott QO, Eliceiri GL (1989) Ultraviolate light-induced inhibition of small nuclear RNA synthesis. J Cell Physiol 138(3):586-592
62. Thirunavukkarasu C, Choudhury K, Ninichuck AJ, Choudhury I, Eliceiri G (1988) Effect of ultraviolate light on the expression of genes for human U1 RNA. J Cell Physiol 137(1):55-64
63. Morra DS, Eliceiri BP, Eliceiri GL (1986) Effect of UV light on small nuclear RNA synthesis: increased inhibition during postirradiation cell incubation. Mol Cell Biol 6(3):745-750